Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has announced an update on its stock buy-back program, revealing the purchase of 8,985 ordinary fully paid shares on the previous day, adding to a total of 40,505 shares bought back before that. The announcement, dated 5th June 2024, is part of a routine daily notification to the ASX under the code CUV, informing investors of the company’s ongoing efforts to repurchase its shares from the market.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
